Matsukiyococokara & Co. · TSE:3088

Matsukiyococokara & — H1 FY2024 Earnings Presentation

15 slides from Matsukiyococokara &'s earnings presentation, Nov 14, 2024

  1. Slide 1: Supplementary Presentation for the Six Months Ended September 30, 2024

    Supplementary Presentation for the Six Months Ended September 30, 2024 November 14, 2024 Copyright 2024 MatsukiyoCocokara & Co. MatsukiyoCocokara & Co. All rights Reserved.

  2. Slide 2: Table of Contents

    Table of Contents Financial Results for 1H FY2024 Financial Summary (YoY) ・・・・・・ 3 Segment Results (YoY) ・・・・・・ 4 Segment Results (YoY) ) Excluding amortization of goodwill and trademark rights associated with the management ・・・・・・ 5 integration with cocokarafine Inc. Net Sales by Product ・・・・・・ 6 B

  3. Slide 3: Financial Summary (YoY)

    Financial Results for 1H FY2024 Financial Summary (YoY)  Sales increased due to the optimal functioning of key strategies, despite a reactionary decline in COVID-19 related products  Operating profit rose due to control of SG&A expenses, which had increased as a result of investment in human capit

  4. Slide 4: Segment Results (YoY)

    Financial Results for 1H FY2024 Segment Results (YoY)  Matsumotokiyoshi Group recorded an increase in sales and profit against the backdrop of increased flow of people in urban areas and downtown and an increase in overseas tourists visiting Japan.  Cocokarafine Group secured an increase in sales

  5. Slide 5: Segment Results (YoY) excluding goodwill and trademark amortization

    Financial Results for 1H FY2024 Segment Results (YoY) Excluding amortization of goodwill and trademark rights totaling 1,809 million yen Reference associated with the management integration with cocokarafine Inc. ((Millions of yen) Six Months Ended Six Months Ended September 30, 2022 September 30, 2

  6. Slide 6: Net Sales by Product

    Financial Results for 1H FY2024 Net Sales by Product  Increase in our focused health and beauty categories  Steady implementation of key strategies led to an improvement in gross profit margin, despite a reactionary decline in COVID-19 related products ((Millions of yen) Net sales Gross profit mar

  7. Slide 7: Balance Sheet

    Financial Results for 1H FY2024 Balance Sheet  As part of its flexible capital policy, the Group executed a share buyback worth 30.9 billion yen during the six months ended September 30, 2024.  Under net assets, capital surplus decreased by 27.2 billion yen due to the cancellation of treasury shar

  8. Slide 8: Statement of Cash Flows

    Financial Results for 1H FY2024 Statement of Cash Flows  Net cash provided by operating activities was approximately 45.1 billion yen mainly due to the recognition of profit before income taxes.  Free cash flow generated during the period totaled 35.4 billion yen, a year-on-year increase of approx

  9. Slide 9: Store Openings, Closings, and Renovations in Japan

    Financial Results for 1H FY2024 Store Openings, Closings, and Renovations in Japan  Actual results for the first half of FY2024 (Unit: No. of stores) Number of stores Openings Closings Renovations Number of stores as of March 31, 2024 in 1H in 1H in 1H as of Sep 30, 2024 Matsumotokiyoshi Group 1,90

  10. Slide 10: FY2024 Financial Forecasts

    Financial Forecasts for FY2024 FY2024 Financial Forecasts  There are no revisions to the consolidated earnings forecast announced on May 10, 2024 (Millions of yen) Full Year FY2023 FY2024 Change Change % to net sales % to net sales (amount) (%) Net sales 1,022,531 1,050,000 27,468 2.7 Gross profit

  11. Slide 11: Shareholder Return

    Financial Forecasts for FY2024 Shareholder Return  Targets set for DOE (dividend on equity) of at least 3% and dividend payout ratio of at least 30%.  We have introduced a progressive dividend policy, whereby dividends are maintained or increased. 35  We will flexibly implement share円buyback, tak

  12. Slide 12: Quarterly Consolidated Financial Results

    【Appendix】 Quarterly Consolidated Financial Results FY2023 FY2024 （Millions of yen/%） 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year Net sales 248,222 259,544 262,566 252,197 1,022,531 259,749 265,979 Gross profit 84,199 89,627 91,074 89,197 354,097 89,241 93,115 Gross profit margin 33.9 34.5 34.7 35.4

  13. Slide 13: Quarterly Segment Results

    【Appendix】 Quarterly Segment Results FY2023 FY2024 （Millions of yen/％） 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year Sales 152,810 159,867 162,999 157,439 633,117 162,010 166,075 Matsumoto- kiyoshi Segment profit 11,783 12,937 14,267 12,753 51,741 12,560 13,647 Group Business Segment profit margin 7.7

  14. Slide 14: Quarterly Net Sales and Gross Profit by Product

    【Appendix】 Quarterly Net Sales and Gross Profit by Product FY2023 FY2024 (Millions of yen/％) 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year Medical and Sales 85,192 91,340 93,264 92,095 361,892 88,378 90,809 pharmaceuti Segment profit 35,218 40,039 40,416 40,961 156,636 37,069 40,665 cal products Segme

  15. Slide 15: Cautionary Statement

    Cautionary Statement This document contains future outlooks such as plans, forecasts, strategies, and others which are not historical fact and these are made by the management’s judgement based on the obtainable information at the time of the disclosure. Actual results may significantly differ from

MatsukiyoCocokara & — H1 FY2024 Earnings Presentation on 6ix